Syngene International Ltd.

Premium

Healthcare

25 September, 2023

TPG-backed firm to absorb Indian drugmaker's contract development biz, go public

An Indian biopharmaceutical company that counts private equity firm TPG as an investor will absorb a local drugmaker’s contract development ......

Premium

Healthcare

24 July, 2023

Advent may rope in new investor for Bharat Serums with neat valuation markup

Mumbai-based biopharmaceutical company Bharat Serums, controlled by private equity major Advent International, is looking to onboard new investor(s) for a ......

Premium

Healthcare

11 September, 2017

Temasek bets on another Indian healthcare company

Singapore state investment firm Temasek Holdings has picked up a minority stake in an Indian drug research company, thereby increasing ......

Premium

Healthcare

18 May, 2017

True North makes partial exit from drug research firm with strong gains

Private equity firm True North has sold a bulk of its stake in a drug research company, harvesting handsome gains ......

Premium

Healthcare

19 August, 2014

Biocon subsidiary Syngene International looking to raise over $50M

Syngene International, a subsidiary of Biocon Ltd, a generics major that also owns the country's largest drug research and development ......